Search results for promacta

GlaxoSmithKline announced that the United States Food and Drug Administration (FDA) has granted Priority Review for Promacta®/Revolade® (eltrombopag) for the short-term treatment of patients with chr read more »
Discuss   Add this link to...  Bury